Drug and Therapeutics Bulletin 1999;37:47-48; doi:10.1136/dtb.1999.37647
Copyright © 1999 by the BMJ Publishing Group Ltd.
Tazarotene - a topical retinoid for psoriasis
Relevant BNF section: 13.5.2
Retinoids have been given systemically for severe psoriasis for several years.1
Tazarotene (Zorac - Allergan), the first retinoid to be marketed as a topical preparation for psoriasis, was recently licensed for mild-to-moderate plaque psoriasis involving up to 10% of the body surface area. Here we assess its place in the management of psoriasis.
Register for email alerts
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
Coming soon!
The DTB archive back to 1962, volume 1, issue 1 will soon be available.
